HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Silvère M van der Maarel Selected Research

Facioscapulohumeral Muscular Dystrophy

12/2021Systemic delivery of a DUX4-targeting antisense oligonucleotide to treat facioscapulohumeral muscular dystrophy.
9/2021Adenine base editing of the DUX4 polyadenylation signal for targeted genetic therapy in facioscapulohumeral muscular dystrophy.
1/2021Profiling Serum Antibodies Against Muscle Antigens in Facioscapulohumeral Muscular Dystrophy Finds No Disease-Specific Autoantibodies.
1/2021p53 convergently activates Dux/DUX4 in embryonic stem cells and in facioscapulohumeral muscular dystrophy cell models.
10/2020The prospects of targeting DUX4 in facioscapulohumeral muscular dystrophy.
10/2020Dnmt3b regulates DUX4 expression in a tissue-dependent manner in transgenic D4Z4 mice.
1/2020Magnetic resonance imaging correlates with electrical impedance myography in facioscapulohumeral muscular dystrophy.
1/2020Consequences of epigenetic derepression in facioscapulohumeral muscular dystrophy.
11/2019DUX4-Induced Histone Variants H3.X and H3.Y Mark DUX4 Target Genes for Expression.
10/2019SMCHD1 mutation spectrum for facioscapulohumeral muscular dystrophy type 2 (FSHD2) and Bosma arhinia microphthalmia syndrome (BAMS) reveals disease-specific localisation of variants in the ATPase domain.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Silvère M van der Maarel Research Topics

Disease

20Facioscapulohumeral Muscular Dystrophy
12/2021 - 08/2011
10Myasthenia Gravis
01/2021 - 04/2012
8Muscle Weakness
01/2021 - 04/2012
8Oculopharyngeal Muscular Dystrophy
04/2014 - 01/2006
6Muscular Diseases (Myopathy)
01/2021 - 06/2005
6Alzheimer Disease (Alzheimer's Disease)
09/2015 - 05/2009
4Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy)
08/2010 - 06/2005
3Neoplasms (Cancer)
12/2021 - 09/2009
3Inborn Genetic Diseases (Disease, Hereditary)
09/2021 - 09/2014
3variable Immunodeficiency syndrome
01/2019 - 06/2011
3Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
01/2018 - 10/2011
3Muscular Dystrophies (Muscular Dystrophy)
05/2013 - 11/2010
2Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2021 - 01/2016
2Autoimmune Diseases (Autoimmune Disease)
01/2021 - 01/2018
2Disease Progression
01/2020 - 05/2013
2Lambert-Eaton Myasthenic Syndrome (Lambert-Eaton Syndrome)
07/2013 - 09/2009
2Dysferlinopathy
05/2013 - 06/2005
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
02/2012 - 09/2009
1Genomic Instability
12/2021
1Proteostasis Deficiencies
01/2021
1Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
01/2020
1Rare Diseases (Rare Disease)
01/2020
1Arhinia, choanal atresia, and microphthalmia
10/2019
1Body Weight (Weight, Body)
01/2019
1Intellectual Disability (Idiocy)
11/2018
1Epilepsy (Aura)
11/2018
1Central Serous Chorioretinopathy
11/2018
1Hearing Loss (Hearing Impairment)
11/2018
1Mitochondrial Diseases (Mitochondrial Disease)
01/2018
1Familial Cerebral Amyloid Angiopathy
01/2018
1Inflammation (Inflammations)
01/2018
1Rhabdomyosarcoma
01/2017
1Hypersensitivity (Allergy)
01/2017
1Muscular Atrophy (Muscle Atrophy)
01/2016
1Amyloid Plaque
08/2015
1Huntington Disease (Huntington's Disease)
03/2015
1Late Onset Disorders
04/2014
1Paralysis (Palsy)
04/2012

Drug/Important Bio-Agent (IBA)

19Proteins (Proteins, Gene)FDA Link
12/2021 - 06/2005
11AntibodiesIBA
01/2021 - 09/2009
9ChromatinIBA
09/2021 - 06/2012
9Immunoglobulin G (IgG)IBA
01/2021 - 04/2012
9AutoantibodiesIBA
01/2021 - 04/2012
9Phosphotransferases (Kinase)IBA
01/2021 - 04/2012
9muskIBA
01/2021 - 12/2012
8Transcription Factors (Transcription Factor)IBA
10/2020 - 04/2013
6Alanine (L-Alanine)FDA Link
04/2014 - 04/2010
6DysferlinIBA
05/2013 - 06/2005
5Cholinergic ReceptorsIBA
01/2019 - 04/2012
4Amyloid (Amyloid Fibrils)IBA
01/2018 - 01/2012
4Poly(A)-Binding Protein IIIBA
04/2014 - 05/2009
3RNA (Ribonucleic Acid)IBA
01/2019 - 08/2011
3EpitopesIBA
01/2018 - 02/2016
3Single-Domain AntibodiesIBA
08/2015 - 03/2015
3Immunoglobulin FragmentsIBA
01/2012 - 06/2005
2DNA (Deoxyribonucleic Acid)IBA
12/2021 - 08/2015
2AntigensIBA
01/2021 - 02/2012
2Amino AcidsFDA Link
01/2018 - 05/2011
2Acetylcholine (Acetylcholine Chloride)FDA Link
01/2017 - 04/2012
2CalpainIBA
08/2010 - 06/2008
2Carrier Proteins (Binding Protein)IBA
04/2010 - 01/2006
2polyalanineIBA
05/2009 - 01/2006
1Antisense OligonucleotidesIBA
12/2021
1AdenineFDA LinkGeneric
09/2021
1NucleotidesIBA
09/2021
1Heterogeneous Nuclear Ribonucleoprotein A1IBA
01/2021
1ElementsIBA
01/2021
1Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2020
1Adenosine Triphosphatases (ATPase)IBA
10/2019
1Pharmaceutical PreparationsIBA
01/2019
1LuciferasesIBA
01/2019
1Monoclonal AntibodiesIBA
01/2019
1neonatal Fc receptorIBA
01/2019
1AgrinIBA
01/2019
1Retinaldehyde (Retinal)IBA
11/2018
1Adrenal Cortex Hormones (Corticosteroids)IBA
11/2018
1Biological ProductsIBA
01/2018
1Fc Receptors (Fc Receptor)IBA
01/2018
1Adenosine Triphosphate (ATP)IBA
01/2018
1Complement System Proteins (Complement)IBA
01/2018
1CarbonIBA
01/2018
1Neurotransmitter Receptors (Neurotransmitter Receptor)IBA
01/2017
1Transfer RNA (tRNA)IBA
01/2017
1Small Interfering RNA (siRNA)IBA
01/2017
1Peptides (Polypeptides)IBA
09/2015
1Liposomes (Liposome)IBA
04/2015
1Glutathione (Reduced Glutathione)IBA
04/2015
1Huntingtin ProteinIBA
03/2015
1polyglutamineIBA
03/2015
1Proteasome Endopeptidase Complex (Proteasome)IBA
04/2014
1UbiquitinIBA
04/2014
1Poly(A)-Binding Proteins (Poly(A)-Binding Protein)IBA
06/2013
1Fibronectins (Fibronectin)IBA
05/2013
1IntegrinsIBA
05/2013
1myasthenia gravis anti-skeletal muscle antibody (ASMA)IBA
12/2012
1Immunoglobulins (Immunoglobulin)IBA
04/2012

Therapy/Procedure

3Therapeutics
01/2020 - 08/2010
1Prostatectomy (Retropubic Prostatectomy)
12/2021
1Injections
01/2019